Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (9)

2023

  1. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset

    European Journal of Clinical Investigation, Vol. 53, Núm. 10

  2. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

  3. Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort

    Frontiers in Endocrinology, Vol. 13

2022

  1. Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

    Journal of Clinical Medicine, Vol. 11, Núm. 17

2021

  1. Proinflammatory and hepatic features related to morbidity and fatal outcomes in covid-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Exploring host genetic polymorphisms involved in SARS-CoV infection outcomes: Implications for personalized medicine in covid-19

    International Journal of Genomics, Vol. 2020

2017

  1. Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation

    Annals of Transplantation, Vol. 22, pp. 141-147

2015

  1. Design and performance of a new severity score for intermediate care

    PLoS ONE, Vol. 10, Núm. 6

  2. Mortality prediction in patients Undergoing Non-invasive ventilation in intermediate care

    PLoS ONE, Vol. 10, Núm. 10